```html

Pestivirus Infection (Bovine Viral Diarrhea) – Comprehensive Medical Guide

Overview

Pestivirus infection refers to a group of diseases caused by viruses of the genus Pestivirus within the family Flaviviridae. The most widely recognized member in cattle is **Bovine Viral Diarrhea Virus (BVDV)**, which causes the disease commonly called Bovine Viral Diarrhea (BVD). While the term “pestivirus infection” can also apply to related viruses in pigs (e.g., Classical Swine Fever) and sheep (e.g., Border Disease), this guide focuses on the cattle form because it is the most prevalent and economically important.

BVD is a **global disease**. The World Organisation for Animal Health (OIE) reports that more than 70% of countries with cattle industries have documented BVDV infections. In the United States, seroprevalence studies estimate that 30‑50% of herds have been exposed, and 10‑20% of individual cattle test positive for antibodies or viral RNA (CDC).

The virus affects **all ages of cattle**, but the clinical picture varies dramatically—from subclinical infections to severe, life‑threatening disease. Understanding the spectrum of disease, how to diagnose it, and what steps can be taken to prevent spread is crucial for producers, veterinarians, and anyone who works with cattle.

Symptoms

Because BVD can manifest in many ways, the following list groups symptoms by the most common clinical forms.

1. Acute (Transient) Infection

• Fever – Often 104 °F (40 °C) or higher, lasting 1‑3 days.
• Diarrhea – Watery to semi‑solid, may contain mucus or blood.
• Loss of appetite – Cattle may stand apart, appear “off feed.”
• Depression/lethargy – Reduced movement, listlessness.
• Respiratory signs – Nasal discharge, coughing, occasional dyspnea.
• Reproductive signs in cows – Early embryonic loss, delayed estrus.

2. Persistent Infection (PI)

PI calves are infected in utero and become lifelong virus shedders.

• Often appear normal at birth but develop poor growth rates.
• Chronic diarrhea and intermittent respiratory disease.
• Frequent secondary bacterial infections (e.g., pneumonia, otitis media).
• Reproductive failure in females (infertility, abortions).
• Higher mortality rates—up to 30% in the first year of life.

3. Mucosal Disease (MD)

MD occurs when a PI animal is super‑infected with a cytopathic BVDV strain.

• Severe, erosive lesions of the oral cavity, esophagus, and stomach.
• Profuse watery diarrhea and vomiting.
• Marked weight loss, dehydration, and profound weakness.
• Almost always fatal within 7–10 days.

4. Reproductive Manifestations

• Abortion – Usually between days 30‑120 of gestation.
• Congenital defects – “Slick” hair coat, cerebellar hypoplasia, ocular anomalies.
• Weak calves – Low birth weight, difficulty nursing.

Causes and Risk Factors

Etiology

BVDV is an RNA virus with two major biotypes: non‑cytopathic (NCP) and cytopathic (CP). Both can cause acute disease, but only NCP strains can cross the placenta and establish persistent infection. The virus spreads primarily via direct contact with infected secretions (nasal discharge, saliva, feces, urine) and indirectly through contaminated equipment, feed, or personnel.

Key Risk Factors

• Presence of PI animals – The biggest source of virus on a farm.
• High animal density – Feedlots, veal operations, and large dairy barns facilitate transmission.
• Poor biosecurity – Shared water troughs, inadequate disinfection, and uncontrolled visitor access.
• Stressful events – Transportation, weaning, and hormonal manipulation can reactivate latent infection.
• Mixed‑species farms – While BVDV is species‑specific, co‑housing with goats/sheep can complicate surveillance because related pestiviruses may cross‑react in serologic tests.

Diagnosis

Accurate diagnosis combines clinical suspicion with laboratory testing. Because many signs overlap with other enteric or respiratory diseases, confirmatory testing is essential.

1. Sample Collection

• Blood (serum or whole blood) – For antibody detection (ELISA) and viral RNA (RT‑PCR).
• Nasal swabs, ear notch tissue, or feces – Preferred for RT‑PCR in acute disease.
• Skin biopsy of the ear notch – The gold standard for identifying PI calves.

2. Laboratory Tests

• ELISA (Enzyme‑Linked Immunosorbent Assay) – Detects antibodies; useful for herd screening.
• RT‑PCR (Reverse‑Transcription Polymerase Chain Reaction) – Detects viral RNA; highly sensitive, can differentiate NCP vs. CP strains.
• Virus Isolation – Performed in specialized labs; less common due to cost.
• Immunohistochemistry – Occasionally used on tissue sections from aborted fetuses.

Interpretation Guidelines (based on OIE and USDA recommendations)

1. Two positive RT‑PCR results from the same animal at least 3 weeks apart confirm a PI status.
2. A single positive PCR in a sick animal indicates acute infection.
3. Positive ELISA in a herd with no recent vaccination suggests natural exposure.

Treatment Options

There is no specific antiviral drug approved for BVDV in cattle. Management focuses on supportive care, controlling secondary infections, and removing sources of virus.

Supportive Care

• Fluid therapy – Oral electrolytes or IV fluids to correct dehydration from diarrhea.
• Nutrition – High‑energy, easily digestible feeds; consider rumen‑protected amino acids for recovering calves.
• Antipyretics – Not routinely used; NSAIDs (e.g., flunixin meglumine) may reduce fever and inflammation.

Secondary Bacterial Infections

Empiric antimicrobial therapy based on culture and sensitivity is recommended for cases with pneumonia, septic arthritis, or severe otitis media. Common choices include:

• Penicillin or ampicillin for streptococcal infections.
• Oxytetracycline or florfenicol for Mannheimia‑hemolytica pneumonia.

Management of Persistent Infection

• Euthanasia or culling of PI animals – The most effective way to eliminate the source of virus.
• Isolate and test close contacts for PI status before reintegration.

Vaccination

While not a treatment for an already infected animal, vaccination is a cornerstone of herd‑level control.

• Both modified‑live and inactivated vaccines are available (e.g., from Boehringer Ingelheim, Zoetis).
• Vaccination protocols typically start at 4–6 weeks of age, with a booster 3–4 weeks later, then annual revaccination.
• Vaccines do not prevent infection in PI animals, so testing before vaccination is essential.

Living with Pestivirus infection (e.g., Bovine Viral Diarrhea)

For producers who have confirmed BVDV in their herd, daily management focuses on minimizing spread and supporting affected animals.

1. Biosecurity Practices

• Quarantine all new arrivals for at least 30 days and test with RT‑PCR and ELISA before mixing.
• Designate “clean” and “dirty” equipment zones; use footbaths and hand sanitizers at entry points.
• Disinfect water troughs, feeding equipment, and tools daily with a 1% sodium hypochlorite solution.

2. Monitoring & Record Keeping

• Maintain a log of all test results, including individual animal IDs, birth dates, and vaccination dates.
• Track reproductive performance (service dates, abortions) to spot trends linked to BVD.

3. Nutrition & Stress Reduction

• Provide clean, fresh water at all times; contaminated water is a known transmission vehicle.
• Implement low‑stress handling protocols—avoid overcrowding, use gentle sorting techniques.
• Supplement with vitamin E and selenium during high‑risk periods (e.g., calving season) to boost immunity.

4. Cow‑Calf Operations

• Test all breeding females annually; remove any newly identified PI cows.
• Consider timed artificial insemination with BVD‑negative semen to reduce vertical transmission.

Prevention

Prevention is a combination of vaccination, strict biosecurity, and herd monitoring.

Vaccination Strategies

• Use a **core vaccine** that includes both BVDV‑1 and BVDV‑2 antigens.
• Employ a “test‑and‑cull” pre‑vaccination program to avoid vaccinating PI animals, which would mask their status.

Biosecurity Checklist

1. Identify and isolate PI animals immediately.
2. Control visitor access; require clean clothing and footwear.
3. Implement a “dry lot” for newly introduced calves for at least 4 weeks.
4. Use disposable needles and syringes; never reuse equipment between animals.
5. Regularly clean and disinfect calving pens.

Herd Health Programs

Many veterinary services offer a “BVD control program” that includes periodic testing, vaccination plans, and data management. Participation has been shown to reduce seroprevalence by 60‑80% within three years (CDC).

Complications

If left unchecked, BVDV can lead to serious health and economic consequences.

• Immune suppression – Increases susceptibility to other pathogens (e.g., Mycoplasma, Salmonella).
• Reproductive losses – Abortions, stillbirths, and infertility reduce herd profitability.
• Chronic respiratory disease – Repeated pneumonia episodes can cause permanent lung damage.
• Weight loss and poor feed efficiency – Leads to higher feed costs and slower market readiness.
• Mucosal disease – Almost invariably fatal; accounts for up to 10% of deaths in herds with undetected PI animals.
• Zoonotic potential – While BVDV does not infect humans, the stress and antimicrobial use associated with the disease can contribute to antimicrobial resistance concerns.

When to Seek Emergency Care

References

• World Organisation for Animal Health (OIE). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 2022.
• Centers for Disease Control and Prevention (CDC). “Bovine Viral Diarrhea Virus (BVDV).” https://www.cdc.gov/animalhealth/zoonoses/bvdv.html.
• Mayo Clinic. “Bovine viral diarrhea (BVD) in cattle.” 2023.
• National Institutes of Health (NIH). “Pestivirus.” https://www.ncbi.nlm.nih.gov/virus/Pestivirus.
• Cleveland Clinic. “Viral infections in livestock: Management and prevention.” 2022.
• Wang, J. et al. “Impact of BVDV control programs on herd health and economics.” Veterinary Microbiology, 2021; 256:108874.

```